|
NL154598B
(nl)
|
1970-11-10 |
1977-09-15 |
Organon Nv |
Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
|
|
US3817837A
(en)
|
1971-05-14 |
1974-06-18 |
Syva Corp |
Enzyme amplification assay
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US3939350A
(en)
|
1974-04-29 |
1976-02-17 |
Board Of Trustees Of The Leland Stanford Junior University |
Fluorescent immunoassay employing total reflection for activation
|
|
US3996345A
(en)
|
1974-08-12 |
1976-12-07 |
Syva Company |
Fluorescence quenching with immunological pairs in immunoassays
|
|
US4275149A
(en)
|
1978-11-24 |
1981-06-23 |
Syva Company |
Macromolecular environment control in specific receptor assays
|
|
US4277437A
(en)
|
1978-04-05 |
1981-07-07 |
Syva Company |
Kit for carrying out chemically induced fluorescence immunoassay
|
|
US4657760A
(en)
|
1979-03-20 |
1987-04-14 |
Ortho Pharmaceutical Corporation |
Methods and compositions using monoclonal antibody to human T cells
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
WO1981001145A1
(en)
|
1979-10-18 |
1981-04-30 |
Univ Illinois |
Hydrolytic enzyme-activatible pro-drugs
|
|
US4366241A
(en)
|
1980-08-07 |
1982-12-28 |
Syva Company |
Concentrating zone method in heterogeneous immunoassays
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
US4957939A
(en)
|
1981-07-24 |
1990-09-18 |
Schering Aktiengesellschaft |
Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
US4472509A
(en)
|
1982-06-07 |
1984-09-18 |
Gansow Otto A |
Metal chelate conjugated monoclonal antibodies
|
|
US4522811A
(en)
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
|
US4474892A
(en)
|
1983-02-16 |
1984-10-02 |
Board Of Trustees Of The Leland Stanford Junior University |
Two-site immunoassays using monoclonal antibodies of different classes or subclasses and test kits for performing same
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
US5169774A
(en)
|
1984-02-08 |
1992-12-08 |
Cetus Oncology Corporation |
Monoclonal anti-human breast cancer antibodies
|
|
US4665897A
(en)
|
1984-05-25 |
1987-05-19 |
Lemelson Jerome H |
Composition and method for detecting and treating cancer
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
US5206344A
(en)
|
1985-06-26 |
1993-04-27 |
Cetus Oncology Corporation |
Interleukin-2 muteins and polymer conjugation thereof
|
|
US4938948A
(en)
|
1985-10-07 |
1990-07-03 |
Cetus Corporation |
Method for imaging breast tumors using labeled monoclonal anti-human breast cancer antibodies
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
US5055459A
(en)
|
1986-06-30 |
1991-10-08 |
Board Of Regents, The University Of Texas |
Selective elimination of malignant cells from bone marrow by bis (acyloxy) propylphosphoramidates
|
|
US4987071A
(en)
|
1986-12-03 |
1991-01-22 |
University Patents, Inc. |
RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
|
|
GB8705477D0
(en)
|
1987-03-09 |
1987-04-15 |
Carlton Med Prod |
Drug delivery systems
|
|
US5223427A
(en)
|
1987-03-31 |
1993-06-29 |
The Scripps Research Institute |
Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain
|
|
US4975278A
(en)
|
1988-02-26 |
1990-12-04 |
Bristol-Myers Company |
Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5047335A
(en)
|
1988-12-21 |
1991-09-10 |
The Regents Of The University Of Calif. |
Process for controlling intracellular glycosylation of proteins
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
US5192660A
(en)
|
1989-04-24 |
1993-03-09 |
The United States Of America As Represented By The Department Of Health And Human Services |
ELISA methods for the determination of human platelet derived growth factor (PDGF) dimer forms present in human tissues and fluids
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
US6020145A
(en)
|
1989-06-30 |
2000-02-01 |
Bristol-Myers Squibb Company |
Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
US5225212A
(en)
|
1989-10-20 |
1993-07-06 |
Liposome Technology, Inc. |
Microreservoir liposome composition and method
|
|
WO1991006667A1
(en)
|
1989-11-06 |
1991-05-16 |
Cell Genesys, Inc. |
Production of proteins using homologous recombination
|
|
AU635008B2
(en)
|
1989-12-13 |
1993-03-11 |
Genelabs Diagnostics Pte Ltd |
Analytical apparatus and method for automated blot assay
|
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
DK0710719T3
(da)
|
1990-01-12 |
2007-07-09 |
Amgen Fremont Inc |
Frembringelse af xenogene antistoffer
|
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6657103B1
(en)
|
1990-01-12 |
2003-12-02 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
JPH049249A
(ja)
|
1990-04-27 |
1992-01-14 |
Kusuda:Kk |
塗型剤吹き付け機
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
DE69127627T2
(de)
|
1990-08-29 |
1998-02-19 |
Genpharm Int |
Produktion und Nützung nicht-menschliche transgentiere zur Produktion heterologe Antikörper
|
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5736348A
(en)
|
1990-11-28 |
1998-04-07 |
Fundacao Oswaldo Cruz (Fiocruz) |
Method for the immunological diagnosis of Chagas' Disease using recombinant antigens
|
|
US5278299A
(en)
|
1991-03-18 |
1994-01-11 |
Scripps Clinic And Research Foundation |
Method and composition for synthesizing sialylated glycosyl compounds
|
|
GB9114948D0
(en)
|
1991-07-11 |
1991-08-28 |
Pfizer Ltd |
Process for preparing sertraline intermediates
|
|
IE922437A1
(en)
|
1991-07-25 |
1993-01-27 |
Idec Pharma Corp |
Recombinant antibodies for human therapy
|
|
US5756096A
(en)
|
1991-07-25 |
1998-05-26 |
Idec Pharmaceuticals Corporation |
Recombinant antibodies for human therapy
|
|
US6136310A
(en)
|
1991-07-25 |
2000-10-24 |
Idec Pharmaceuticals Corporation |
Recombinant anti-CD4 antibodies for human therapy
|
|
WO1993010260A1
(en)
|
1991-11-21 |
1993-05-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Controlling degradation of glycoprotein oligosaccharides by extracellular glycosisases
|
|
JPH05244988A
(ja)
|
1992-03-04 |
1993-09-24 |
Green Cross Corp:The |
抗組織因子モノクローナル抗体、及びこれによる免疫抑制剤
|
|
US5489508A
(en)
|
1992-05-13 |
1996-02-06 |
University Of Texas System Board Of Regents |
Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
|
|
JPH06105910A
(ja)
|
1992-09-30 |
1994-04-19 |
Toyobo Co Ltd |
抗ヌクレオリン抗体吸着材
|
|
NZ258392A
(en)
|
1992-11-13 |
1997-09-22 |
Idec Pharma Corp |
Chimeric and radiolabelled antibodies to the b lymphocyte cellsurface antigen bp35 (cd-20) and their use in the treatment of b cell lymphona
|
|
PT744958E
(pt)
|
1994-01-31 |
2003-11-28 |
Univ Boston |
Bancos de anticorpos policlonais
|
|
JPH07242566A
(ja)
|
1994-03-01 |
1995-09-19 |
Kirin Brewery Co Ltd |
免疫抑制剤
|
|
US5534615A
(en)
|
1994-04-25 |
1996-07-09 |
Genentech, Inc. |
Cardiac hypertrophy factor and uses therefor
|
|
US5691447A
(en)
|
1995-03-24 |
1997-11-25 |
Tanox Biosystems, Inc. |
GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
|
|
US6096871A
(en)
|
1995-04-14 |
2000-08-01 |
Genentech, Inc. |
Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
|
|
EP1978033A3
(en)
|
1995-04-27 |
2008-12-24 |
Amgen Fremont Inc. |
Human antibodies derived from immunized xenomice
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US6096532A
(en)
|
1995-06-07 |
2000-08-01 |
Aastrom Biosciences, Inc. |
Processor apparatus for use in a system for maintaining and growing biological cells
|
|
EP0883344B2
(en)
|
1995-12-15 |
2010-06-09 |
VIRxSYS Corporation |
Therapeutic molecules generated by trans-splicing
|
|
US5836943A
(en)
|
1996-08-23 |
1998-11-17 |
Team Medical, L.L.C. |
Electrosurgical generator
|
|
US6048703A
(en)
|
1996-11-15 |
2000-04-11 |
Cephalon, Inc. |
Methods for detecting cell apoptosis
|
|
ATE549918T1
(de)
|
1996-12-03 |
2012-04-15 |
Amgen Fremont Inc |
Menschliche antikörper, die ausdrücklich menschliches tnf alpha binden
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
EP1007669A1
(en)
|
1997-03-12 |
2000-06-14 |
Institut Pasteur |
A novel cell surface receptor for hiv retroviruses, therapeutic and diagnostic uses
|
|
US6291643B1
(en)
|
1997-06-05 |
2001-09-18 |
Board Of Reports, The University Of Texas System |
Apaf-1 an activator of caspase-3
|
|
EP0985039B1
(en)
|
1997-06-12 |
2008-02-20 |
Novartis International Pharmaceutical Ltd. |
Artificial antibody polypeptides
|
|
US6339075B1
(en)
|
1997-06-30 |
2002-01-15 |
The University Of British Columbia |
Use of dextran and other polysaccharides to improve mucus clearance
|
|
AU6053898A
(en)
|
1997-08-04 |
1999-02-22 |
Burnham Institute, The |
A cell-free system of mitochondria-dependent apoptosis, and methods of use ther eof
|
|
US6325785B1
(en)
|
1997-08-14 |
2001-12-04 |
Sherwood Services Ag |
Sputum trap manifold with nested caps
|
|
US5925334A
(en)
|
1997-08-27 |
1999-07-20 |
Rubin; Bruce K. |
Use of surface active agents to promote mucus clearance
|
|
US5932475A
(en)
|
1997-12-12 |
1999-08-03 |
Incyte Pharmaceuticals, Inc. |
Human nucleolin-like protein
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
WO1999053057A1
(en)
|
1998-04-10 |
1999-10-21 |
Chugai Research Institute For Molecular Medicine, Inc. |
Protein and gene participating in the differentiation of immortalized cells
|
|
US6306404B1
(en)
|
1998-07-14 |
2001-10-23 |
American Cyanamid Company |
Adjuvant and vaccine compositions containing monophosphoryl lipid A
|
|
DE69937835T2
(de)
|
1998-09-24 |
2009-01-02 |
Promega Corp., Madison |
Antikörper für apoptosemarker und anwendungsverfahren
|
|
PT1181304E
(pt)
|
1999-04-08 |
2008-01-23 |
Antisoma Res Ltd |
Actividade antiproliferativa de oligonucleótidos ricos em g e método de utilização dos mesmos para ligação a nucleolina
|
|
EP1173486A1
(en)
|
1999-04-15 |
2002-01-23 |
Merck Frosst Canada & Co. |
Antibodies that recognize app cleaved by caspases and methods of use
|
|
NZ517929A
(en)
|
1999-09-25 |
2004-02-27 |
Univ Iowa Res Found |
Immunostimulatory nucleic acids
|
|
US6165786A
(en)
*
|
1999-11-03 |
2000-12-26 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of nucleolin expression
|
|
ATE365327T1
(de)
|
1999-11-08 |
2007-07-15 |
Eisai Co Ltd |
Verfahren zum nachweis von zelltod mittels cytochrom c.
|
|
JP2001213804A
(ja)
|
2000-01-31 |
2001-08-07 |
Chugai Pharmaceut Co Ltd |
抗組織因子抗体の複合体
|
|
WO2001068836A2
(en)
|
2000-03-16 |
2001-09-20 |
Genetica, Inc. |
Methods and compositions for rna interference
|
|
KR20080023768A
(ko)
|
2000-03-30 |
2008-03-14 |
화이트헤드 인스티튜트 포 바이오메디칼 리서치 |
Ｒｎａ 간섭의 ｒｎａ 서열 특이적인 매개체
|
|
EP1286693A4
(en)
|
2000-06-02 |
2005-07-13 |
Univ Connecticut Health Ct |
COMPLEXES OF ALPHA (2) MACROGLOBULIN AND ANTIGENIC MOLECULES FOR USE IN IMMUNOTHERAPY
|
|
US20020028488A1
(en)
|
2000-06-19 |
2002-03-07 |
Sujay Singh |
Transgenic avian species for making human and chimeric antibodies
|
|
EP1170874A1
(de)
*
|
2000-07-05 |
2002-01-09 |
Infineon Technologies AG |
Empfangseinrichtung, insbesondere für den Mobilfunk
|
|
DE10037861A1
(de)
|
2000-08-01 |
2002-02-14 |
Max Delbrueck Centrum |
Mittel zur Therapie maligner Erkrankungen
|
|
WO2002012437A2
(en)
|
2000-08-03 |
2002-02-14 |
Schooten Wim Van |
Production of humanized antibodies in transgenic animals
|
|
CZ302719B6
(cs)
|
2000-12-01 |
2011-09-21 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Izolovaná molekula dvouretezcové RNA, zpusob její výroby a její použití
|
|
DE10059821A1
(de)
|
2000-12-01 |
2002-06-13 |
Clariant Gmbh |
Tensidfreie kosmetische, dermatologische und pharmazeutische Mittel
|
|
FR2817875B1
(fr)
|
2000-12-07 |
2005-03-18 |
Technopharm |
Procede de preparation d'un anticorps monoclonal humain, de fragments de celui-ci ou d'anticorps comprenant de tels fragments, les anticorps ainsi obtenus et leur utilisation
|
|
AU2002245317A1
(en)
|
2001-01-24 |
2002-08-06 |
Protein Design Labs |
Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer
|
|
JP3676991B2
(ja)
|
2001-07-05 |
2005-07-27 |
松下電器産業株式会社 |
無線通信装置及び無線通信方法
|
|
DE60208562T2
(de)
|
2001-07-16 |
2006-11-09 |
Arla Foods Amba |
Verfahren zur herstellung von tagatose
|
|
AU2002362436A1
(en)
|
2001-10-03 |
2003-04-14 |
Rigel Pharmaceuticals, Inc. |
Modulators of lymphocyte activation and migration
|
|
US7544767B2
(en)
|
2002-04-05 |
2009-06-09 |
Burnham Institute For Medical Research |
HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
|
|
AU2003228431A1
(en)
|
2002-04-05 |
2003-10-27 |
The Burnham Institute |
Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells
|
|
US7357928B2
(en)
|
2002-04-08 |
2008-04-15 |
University Of Louisville Research Foundation, Inc. |
Method for the diagnosis and prognosis of malignant diseases
|
|
US7541150B2
(en)
*
|
2002-04-08 |
2009-06-02 |
University Of Louisville Research Foundation, Inc |
Method for the diagnosis and prognosis of malignant diseases
|
|
CA2489520A1
(en)
|
2002-06-26 |
2004-01-08 |
University Of Louisville Research Foundation, Inc. |
A method for the detection of apoptosis
|
|
US20070224201A1
(en)
|
2002-10-02 |
2007-09-27 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
EP1597280B2
(en)
*
|
2003-02-26 |
2016-08-24 |
Institute for Research in Biomedicine |
Monoclonal antibody production by ebv transformation of b cells
|
|
GB2398783A
(en)
|
2003-02-26 |
2004-09-01 |
Antonio Lanzavecchia |
A method for producing immortalised human B memory lymphocytes
|
|
WO2004091383A2
(en)
|
2003-04-01 |
2004-10-28 |
Genzyme Corporation |
Breast endothelial cell expression patterns
|
|
CN1802176A
(zh)
|
2003-04-09 |
2006-07-12 |
健泰科生物技术公司 |
治疗对tnf－alpha抑制剂应答不充分的患者中的自身免疫病
|
|
TW200504210A
(en)
|
2003-07-30 |
2005-02-01 |
Chin-Tarng Lin |
A nucleolin antisense inhibiting growth of cancer cell
|
|
US20050187176A1
(en)
|
2003-10-10 |
2005-08-25 |
Bates Paula J. |
Method for inhibiting NF-kappa B signaling and use to treat or prevent human diseases
|
|
EP1755686A2
(en)
|
2004-06-02 |
2007-02-28 |
Sidney Kimmel Cancer Center |
Imaging and therapeutic agents targeting proteins expressed on endothelial cell surface
|
|
EP1756165A2
(en)
|
2004-06-02 |
2007-02-28 |
Sidney Kimmel Cancer Center |
Tissue-specific imaging and therapeutical agents targeting proteins expressed on lung endothelial cell surface
|
|
US7494779B2
(en)
|
2004-06-14 |
2009-02-24 |
Li-Te Chin |
Method for producing human antibodies to human CD152 with properties of agonist, antagonist, or inverse agonist
|
|
WO2006050058A2
(en)
|
2004-10-28 |
2006-05-11 |
The General Hospital Corporation |
Methods of detection and therapy of inflamed tissues using immune modulation
|
|
TW200714289A
(en)
|
2005-02-28 |
2007-04-16 |
Genentech Inc |
Treatment of bone disorders
|
|
CN1862258B
(zh)
|
2005-05-12 |
2012-05-30 |
清华大学 |
核仁素辅助的癌症诊断与治疗方法
|
|
EP1910420B1
(en)
|
2005-07-29 |
2011-05-18 |
Life Sciences Research Partners VZW |
Human inhibitory anti-factor viii antibodies binding to the a2 domain
|
|
WO2007016466A2
(en)
|
2005-07-29 |
2007-02-08 |
Sloan-Kettering Institute For Cancer Research |
Single wall nanotube constructs and uses therefor
|
|
US20070065919A1
(en)
|
2005-08-23 |
2007-03-22 |
Herman Groen |
Methods of producing stable B-lymphocytes
|
|
WO2007041213A2
(en)
*
|
2005-09-30 |
2007-04-12 |
St. Jude Children's Research Hospital |
Methods for regulation of p53 translation and function
|
|
HUE037580T2
(hu)
|
2005-12-09 |
2018-09-28 |
Academisch Medisch Centrum Bij De Univ Van Amsterdam |
Eszközök és eljárások ellenanyag-termelõ sejtek stabilitásának befolyásolására
|
|
BRPI0619908A2
(pt)
|
2005-12-16 |
2011-10-25 |
Ribovax Biotechnologies Sa |
método para imortalização de uma população de células, população de células, população de células oligoclonal ou monoclonal, cultura celular, sobrenadante de uma cultura celular, biclioteca de dnas, uso de uma população de células, cultura celular, sobrenadante ou biblioteca de dnas, kit para identificar e produzir um anticorpo monoclonal, método para produzir uma cultura celular, e método para produzir um anticorpo monoclonal
|
|
JP2007319153A
(ja)
|
2006-06-02 |
2007-12-13 |
Takashi Otsu |
核酸リガンドと中和剤との組み合わせ製剤
|
|
WO2008008858A2
(en)
|
2006-07-12 |
2008-01-17 |
Trellis Bioscience, Inc. |
Cellspot™ applications
|
|
US7590925B2
(en)
|
2006-09-05 |
2009-09-15 |
Mediatek Inc. |
Apparatus and method for detecting puncture position in a symbol stream encoded by punctured convolutional coding scheme
|
|
AU2008232506A1
(en)
|
2007-04-02 |
2008-10-09 |
Genentech, Inc. |
Biological markers predictive of rheumatoid arthritis response to B-cell antagonists
|
|
WO2008138017A2
(en)
|
2007-05-08 |
2008-11-13 |
Beth Israel Deaconess Medical Center, Inc. |
Methods and compositions for modifying t cell immune responses and inflammation
|
|
EP2006304A1
(en)
|
2007-06-22 |
2008-12-24 |
Stiftung Für Diagnostische Forschung |
Anti-HPA-5b monoclonal antibody
|
|
JP5797403B2
(ja)
|
2007-08-03 |
2015-10-21 |
エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント |
ヒトモノクローナル抗体およびそれを産生する方法
|
|
US20090191244A1
(en)
|
2007-09-27 |
2009-07-30 |
Children's Medical Center Corporation |
Microbubbles and methods for oxygen delivery
|
|
US20090226914A1
(en)
|
2007-12-31 |
2009-09-10 |
Bates Paula J |
Methods and products to target, capture and characterize stem cells
|
|
US20090215178A1
(en)
|
2008-02-22 |
2009-08-27 |
Zequn Tang |
Methods to enhance the stability and homogeneity of transgene expression in clonal cell lines
|
|
US8231895B2
(en)
|
2008-05-22 |
2012-07-31 |
Universidade De Coimbra |
Targeted delivery to human diseases and disorders
|
|
WO2010010549A2
(en)
|
2008-07-23 |
2010-01-28 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods of altering peripheral b cell populations and uses thereof
|
|
WO2010075249A2
(en)
|
2008-12-22 |
2010-07-01 |
Genentech, Inc. |
A method for treating rheumatoid arthritis with b-cell antagonists
|
|
JP2013508399A
(ja)
|
2009-10-21 |
2013-03-07 |
ヘルス リサーチ インコーポレイテッド |
腫瘍イメージングの増強用のｐａａナノ粒子
|
|
US20110111002A1
(en)
|
2009-11-12 |
2011-05-12 |
Calin Viorel Pop |
Transport and delivery of glutathione into human cells using gold nanoparticles
|
|
CN102770529B
(zh)
|
2009-11-17 |
2018-06-05 |
Musc研究发展基金会 |
针对人核仁素的人单克隆抗体
|
|
WO2011119058A2
(en)
|
2010-03-22 |
2011-09-29 |
Universidade De Coimbra |
F3-peptide targeted lipid-based nanoparticles useful for the treatment of angiogenesis-dependent diseases
|
|
ES2572915T3
(es)
|
2011-06-02 |
2016-06-03 |
The University Of Louisville Research Foundation, Inc. |
Nanopartículas conjugadas a un agente antinucleolina
|